Drug Master Files for: LITHIUM CITRATE
✉ Email this page to a colleague
LITHIUM CITRATE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
1074 | I | II | 6/27/1967 | SOLVAY PHARMACEUTICALS | MANUFACTURING CONTROL INFORMATION FOR--LITHIUM CARBONATE |
1190 | I | II | 5/24/1968 | LYNE LABORATORIES INC | LITHIUM CARBONATE TABLETS |
1241 | A | II | 9/30/1968 | FMC LITHIUM SUB FMC CORP | LITHIUM CARBONATE |
1320 | I | II | 2/10/1969 | SOLVAY PHARMACEUTICALS | LITHIUM CITRATE SYRUP |
15677 | A | II | 10/18/2001 | LEK PHARMACEUTICALS DD | LITHIUM CARBONATE A SUBSTANCE |
1830 | I | II | 12/9/1971 | SIGMA CHEMICAL CO | CARBAMYL PHOSPHATE, DILITHIUM SALT |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information